Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated Advanced NSCLC”

112 trials

Showing 20 of 112 results

Testing effectiveness (Phase 2)Looking for participantsNCT05098132
What this trial is testing

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerUntreated Advanced NSCLC+1 more
Synthekine 364
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Large-scale testing (Phase 3)Active Not RecruitingNCT06472076
What this trial is testing

Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 88
Testing effectiveness (Phase 2)Ended earlyNCT00434226
What this trial is testing

Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 56
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT04499794
What this trial is testing

The Study of Exosome EML4-ALK Fusion in NSCLC Clinical Diagnosis and Dynamic Monitoring

Who this might be right for
Untreated Advanced NSCLC PatientsFISH Identified ALK Fusion Positive or Negative
Chinese Academy of Medical Sciences 75
Post-approval studies (Phase 4)UnknownNCT03768037
What this trial is testing

Anlotinib Plus Pemetrexed or Pemetrexed for Previously Untreated Elderly (>=70) or PS=2 Non-squamous NSCLC

Who this might be right for
Advanced Non-squamous NSCLC
Guangdong Association of Clinical Trials 106
Large-scale testing (Phase 3)Study completedNCT02106546
What this trial is testing

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

Who this might be right for
Squamous Non-Small Cell Lung Cancer
AbbVie 970
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00994097
What this trial is testing

NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
AGC Biologics S.p.A. 121
Testing effectiveness (Phase 2)Study completedNCT00642759
What this trial is testing

Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Massachusetts General Hospital 36
Large-scale testing (Phase 3)Study completedNCT00752115
What this trial is testing

Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Hamamatsu University 120
Testing effectiveness (Phase 2)Study completedNCT00071188
What this trial is testing

ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)UnknownNCT00616031
What this trial is testing

Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Kyoto University 150
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Testing effectiveness (Phase 2)UnknownNCT05812534
What this trial is testing

Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Second Affiliated Hospital of Nanchang University 36
Early research (Phase 1)Study completedNCT01466647
What this trial is testing

The IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Axelar AB 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04746924
What this trial is testing

Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Who this might be right for
Non-small Cell Lung CancerNSCLC
BeiGene 662
Testing effectiveness (Phase 2)Study completedNCT00165334
What this trial is testing

Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Dana-Farber Cancer Institute 53
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation